DE69634024D1 - Adjuvans für vitale Impfstoffe - Google Patents

Adjuvans für vitale Impfstoffe

Info

Publication number
DE69634024D1
DE69634024D1 DE69634024T DE69634024T DE69634024D1 DE 69634024 D1 DE69634024 D1 DE 69634024D1 DE 69634024 T DE69634024 T DE 69634024T DE 69634024 T DE69634024 T DE 69634024T DE 69634024 D1 DE69634024 D1 DE 69634024D1
Authority
DE
Germany
Prior art keywords
adjuvant
vaccines
vital
compositions
squlane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69634024T
Other languages
English (en)
Other versions
DE69634024T2 (de
Inventor
Richard Norman Hjorth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825435&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69634024(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of DE69634024D1 publication Critical patent/DE69634024D1/de
Application granted granted Critical
Publication of DE69634024T2 publication Critical patent/DE69634024T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE69634024T 1995-06-02 1996-05-29 Adjuvans für vitale Impfstoffe Expired - Lifetime DE69634024T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/459,600 US5718904A (en) 1995-06-02 1995-06-02 Adjuvants for viral vaccines
US459600 1995-06-02

Publications (2)

Publication Number Publication Date
DE69634024D1 true DE69634024D1 (de) 2005-01-20
DE69634024T2 DE69634024T2 (de) 2005-12-08

Family

ID=23825435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69634024T Expired - Lifetime DE69634024T2 (de) 1995-06-02 1996-05-29 Adjuvans für vitale Impfstoffe

Country Status (13)

Country Link
US (1) US5718904A (de)
EP (1) EP0745387B1 (de)
JP (1) JP4344017B2 (de)
KR (1) KR970000248A (de)
CN (1) CN1141810A (de)
AT (1) ATE284710T1 (de)
AU (1) AU712972B2 (de)
CA (1) CA2177668C (de)
DE (1) DE69634024T2 (de)
DK (1) DK0745387T3 (de)
ES (1) ES2233955T3 (de)
HU (1) HUP9601466A2 (de)
NZ (1) NZ286699A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165481A (en) * 1997-12-25 2000-12-26 Nippon Petrochemicals Company, Inc. Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
PL1613346T3 (pl) * 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
KR20090051129A (ko) * 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
CN1315533C (zh) * 2004-06-24 2007-05-16 上海市农业科学院畜牧兽医研究所 猪细小病毒油乳剂灭活疫苗
US20060228369A1 (en) * 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
DK1909830T3 (da) * 2005-08-02 2011-12-19 Novartis Vaccines & Diagnostic Formindskelse af interferens mellem olieholdige adjuvanser og antigener indeholdende overfladeaktivt middel
FR2896162B1 (fr) * 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
BRPI0706709B8 (pt) * 2006-01-26 2021-05-25 Pah Usa 15 Llc composição e processo para preparar a composição
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
TR201807756T4 (tr) 2006-09-26 2018-06-21 Infectious Disease Res Inst Sentetik adjuvan içeren aşı bileşimi.
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
EP2437753B1 (de) 2009-06-05 2016-08-31 Infectious Disease Research Institute Synthetische glucopyranosyl-lipid-adjuvanzien und impfstoffzusammensetzungen die diese enthalten
CN102946900A (zh) 2010-03-11 2013-02-27 免疫设计公司 用于大流行流感的疫苗
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US20120288515A1 (en) 2011-04-27 2012-11-15 Immune Design Corp. Synthetic long peptide (slp)-based vaccines
RS57420B1 (sr) 2012-05-16 2018-09-28 Immune Design Corp Vakcine za hsv-2
CN102764431B (zh) * 2012-08-03 2014-10-22 江苏省农业科学院 一种猪支原体肺炎雾化活疫苗及其制备与检验方法
CN104043119B (zh) * 2013-03-13 2016-05-25 上海医药工业研究院 一种新型疫苗佐剂及其制备方法
CA2909221A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
WO2015136056A1 (en) 2014-03-12 2015-09-17 Bavarian Nordic A/S Use of oil and water emulsions for increasing b cell responses with modified vaccinia ankara virus
WO2020044267A1 (en) 2018-08-29 2020-03-05 Centre Hospitalier Universitaire Vaudois Ebola vaccine compositions and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4466957A (en) * 1982-02-25 1984-08-21 American Home Products Corporation Vaccine adjuvants
DE3446515A1 (de) * 1984-12-20 1986-06-26 Behringwerke Ag, 3550 Marburg Oeladjuvierte vaccine und verfahren zu ihrer herstellung
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion

Also Published As

Publication number Publication date
JP4344017B2 (ja) 2009-10-14
ATE284710T1 (de) 2005-01-15
DK0745387T3 (da) 2005-02-21
EP0745387A3 (de) 1998-03-11
JPH08325163A (ja) 1996-12-10
CA2177668A1 (en) 1996-12-03
NZ286699A (en) 1997-10-24
KR970000248A (ko) 1997-01-21
CN1141810A (zh) 1997-02-05
EP0745387B1 (de) 2004-12-15
CA2177668C (en) 2009-02-24
AU5457596A (en) 1996-12-12
HU9601466D0 (en) 1996-07-29
US5718904A (en) 1998-02-17
AU712972B2 (en) 1999-11-18
HUP9601466A2 (en) 1997-03-28
DE69634024T2 (de) 2005-12-08
ES2233955T3 (es) 2005-06-16
EP0745387A2 (de) 1996-12-04

Similar Documents

Publication Publication Date Title
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
HU9601462D0 (en) Adjuvants for viral vaccines
NO982497D0 (no) Vaksine-sammensetninger for inntak gjennom nesen
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
NO975620L (no) Immunologiske kombinasjonssammensetninger og fremgangsmåter
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
FI954514A0 (fi) 3-O-deasyloitua monofosforyylilipidiä A sisältävä rokotekoostumus
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
DE69738271D1 (de) Rotavirus-impfstoff
PT789590E (pt) Imunopotenciacao induzida por quitosano
ITRM940495A0 (it) "procedimento per la levigatura dello spigolo di fette di semiconduttori".
IT1269916B (it) Procedimento migliorato per la sintesi di dimetilcarbonato
ITMI931680A0 (it) Procedimento per la preparazione di alcansolfonammidi
FI894653A0 (fi) Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare.
GB9018061D0 (en) Compositions for vaccines
IT1240470B (it) Procedimento per la preparazione di un gel di poliacrilato di sodio.
IT9022507A0 (it) Procedimento per la preparazione di n-(26ammino63,5-dibromo-benzil)-trans-4-amminocicloesanolo3.
ITMI930520A1 (it) Procedimento per la preparazione di disperdenti solfonati.
ITTO940505A0 (it) Procedimento per l'attuazione di microgiunti e macchina per l'attuazione di tale procedimento.
ITRM920074A1 (it) Procedimento per la preparazione di vaccini, e vaccini cosi' ottenibili.
ITMI930340A1 (it) Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina
ITMI922378A1 (it) Procedimento per la stabilizzazione di residui e bitumi.
ITTO920591A0 (it) Procedimento per la preparazione di n-fosfonometilglicina.
IT216687Z2 (it) Confezione protettiva per l'esposizione di padelle.
ITVI910034A1 (it) Manipolo pneumatico per microsabbiatrici e sabbiatrici o simili.

Legal Events

Date Code Title Description
8363 Opposition against the patent